Cord Blood America Offers $50,000 Guarantee That Stem Cells It Stores Will Engraft in Transplant Procedure

LAS VEGAS, Aug. 27 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced a $50,000 Quality Service Guarantee.

Detailed at http://www.corcell.com, the Guarantee will pay the owner of umbilical cord blood stem cells $50,000 if the stored stem cells are used in a hematopoietic stem cell transplant and the stem cells fail to engraft.

"The funds would defray the cost of procurement of an alternative stem cell source, if medically indicated," said Matthew L. Schissler, Chairman, CEO and co-founder.  "We take our responsibility for your child's cord blood very seriously.  Our commitment to stand behind our service is never more important than if the time comes for a family to use the cord blood they have entrusted us to store."

Cord Blood America also announced that case managers nationwide also can now receive credit for the continuing education program offered by the Company on the value of cord blood collection as a potentially life-saving resource for treating serious diseases.  "Case managers are employed by insurance companies and educating them on the value of cord blood storage is a very valuable resource," said Mr. Schissler.

"Case managers, like nurses, need to take advantage of mandatory continuing education programs.  Educating key people in the medical community on the enormous potential of stem cell storage will, we believe, pay significant dividends for our Company," Mr. Schissler said.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.

SOURCE Cord Blood America, Inc.